NCT03847974: A trial that was reported late by LIB Therapeutics LLC
This trial has reported, although it was 285 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT03847974 |
|---|---|
| Title | Open-Label Extension, Phase 2b Study to Evaluate the Longer Term Efficacy and Safety of LIB003 in Patients on Stable Lipid Lowering Therapy Requiring Additional LDL-C Reduction |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Feb. 14, 2019 |
| Completion date | April 7, 2020 |
| Required reporting date | April 7, 2021, midnight |
| Actual reporting date | Jan. 17, 2022 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 285 |